About Index Trending news
Analyze
Pricing
Vivo Capital

Vivo Capital

Work at Vivo Capital? Add yourself to this profile

Vivo Capital

Edit Profile
More info

Elsewhere

Also headquartered in Palo Alto

Tesla Motors Tesla Motors Theranos Theranos VMware VMware Pebble Pebble Hewlett-Packard Hewlett-Packard NEST NEST Waze Waze Accel Accel Flipboard Flipboard Palantir Palantir

Companies in the same industry

Ignition Partners Ignition Partners Susa Ventures Susa Ventures investiere investiere FundsIndia FundsIndia Kapitall Kapitall Entrepreneur First Entrepreneur First HelloBit. HelloBit. JuiceLabs JuiceLabs National Research Foundation Singapore National Research Foundation Singapore SESTERTIUM SESTERTIUM

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 14

Portfolio

Portfolio tracker
Add info

Investment profile

Target markets
Health Care Biotechnology

Activity

Past year's investments

- Vivo Capital participated in 10 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $365,500,000 (averaging $36,550,000 per round).

Latest rounds

- Homology Medicines: Venture capital (Series B) ($83.5M)
- Menlo Therapeutics: Venture capital (Series C) ($50M)
- Zai Lab: Venture capital (Series C) ($30M)

Main Co-investors

- Rock Springs Capital
- RA Capital Management
- OrbiMed

Kala Pharmaceuticals

Kala Pharmaceuticals

Biotechnology
Total funding
$109.2M in 4 rounds from 23 investors
By Vivo Capital
$68M Series C in Apr, 2016
SentreHEART, Inc.

SentreHEART, Inc.

Health Care
Total funding
$61M in 2 rounds from 10 investors
By Vivo Capital
$35M Series D in Sep, 2016
Zai Lab

Zai Lab

Health and Wellness +2
Total funding
$130M in 2 rounds from 9 investors
By Vivo Capital
$30M Series C in Jun, 2017
Impel NeuroPharma

Impel NeuroPharma

Health Care +1
Total funding
$40.3M in 5 rounds from 7 investors
By Vivo Capital
$36M Series C in Dec, 2016
Outpost Medicine

Outpost Medicine

Biotechnology +1
Total funding
$41M in 1 rounds from 5 investors
By Vivo Capital
$41M Series A in Mar, 2016
Homology Medicines

Homology Medicines

Health Care +1
Total funding
$127M in 2 rounds from 17 investors
By Vivo Capital
$83.5M Series B in Aug, 2017
Tricida, Inc.

Tricida, Inc.

Health Care +2
Total funding
$55M in 1 rounds from 5 investors
By Vivo Capital
$55M Series C in Jul, 2016
Fortis Therapeutics

Fortis Therapeutics

Biotechnology +1
Total funding
$18M in 1 rounds from 5 investors
By Vivo Capital
$18M Series A in Sep, 2016
ReadCoor

ReadCoor

Location Based Services +3
Total funding
$25.5M in 2 rounds from 5 investors
By Vivo Capital
$23M Series A in Sep, 2016
Ascendis Pharma A/S

Ascendis Pharma A/S

Biotechnology
Total funding
$60M in 1 rounds from 6 investors
By Vivo Capital
$60M Series D in Dec, 2014
Biohaven Pharmaceuticals

Biohaven Pharmaceuticals

Biotechnology
Total funding
$100M in 2 rounds from 13 investors
By Vivo Capital
$80M Venture Capital in Nov, 2016
Angiotech Pharmaceuticals

Angiotech Pharmaceuticals

Health Care +1
Total funding
An undisclosed amount in 1 rounds from 9 investors
By Vivo Capital
undisclosed deal in Mar, 2017
Platelet BioGenesis

Platelet BioGenesis

Biotechnology
Total funding
$10M in 1 rounds from 5 investors
By Vivo Capital
$10M Series A in Jun, 2017
Menlo Therapeutics

Menlo Therapeutics

Biotechnology
Total funding
$50M in 1 rounds from 9 investors
By Vivo Capital
$50M Series C in Jul, 2017

Want to see the complete list?
Go Pro!